A pending leadership change at Express Scripts drew favorable early reviews from Wall Street analysts, but shares of the nation's largest pharmacy benefits manager fell early Thursday, a day after it ...
Kroger pharmacies are once again back in Express Scripts’ network, two years after the grocer kicked the massive pharmacy benefit manager to the curb over its allegedly unsustainable pricing model.
The clocks are ticking for Express Scripts, writes Stephen E. Littlejohn. Having achieved formidable “size and scale,” how will the nation’s largest pharmacy benefit manager synchronize with ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The Federal Trade Commission has paused its settlement review involving Express ...
DAYTON, Ohio (WDTN) — After more than a two-year hiatus, Kroger is welcoming back Express Scripts customers for health and pharmacy needs. Kroger announced Feb. 5 that an agreement has been reached ...
Earlier this week, the Federal Trade Commission paused its administrative case against major pharmacy benefit managers, including Cigna’s Express Scripts and Evernorth Health, staying proceedings and ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US health insurer Anthem has filed a lawsuit against Express Scripts, which manages the process of filling ...
The company is collaborating with CPESN USA to bring more services to customers at independent pharmacies across the country. The pharmacy landscape continues to evolve. Express Scripts announced that ...
Express Scripts DRC Stock Price History Explore Express Scripts DRC stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to ...
Express Scripts has announced a plan to cut patient co-pays for insulin products at $25 a month ahead of a pricing showdown with US politicians next week. The cap is part of a “patient assurance ...
US health insurance manager Express Scripts says it will be able to supply a low-cost version of anti-parasitic medicine Daraprim, circumventing the high-cost version marketed by Turing. The decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results